Day: August 9, 2022

The Keg Royalties Income Fund Announces Second Quarter 2022 Results

The Keg Royalties Income Fund Announces Second Quarter 2022 Results

Not for distribution to U.S. News wire services or dissemination in the U.S. VANCOUVER, British Columbia, Aug. 09, 2022 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) is pleased to announce its financial results for the three months ended June 30, 2022 (the “quarter”) and the six months ended June 30, 2022 (“YTD”). HIGHLIGHTS Royalty Pool sales(1) up 197.4% to $176.4M for the quarter and up 148.7% to $318.1M YTD KRL system sales(1) up 197.3% to $176.4M for the quarter and up 148.7% to $318.1M YTD Distributable cash(1) up 199.6% to 29.8 cents/Fund unit for the quarter and up 181.2% to 51.9 cents/Fund unit YTD Payout ratio(2) was 95.2% for the quarter and 109.3% YTD Royalty Pool sales reported by the 107 Keg restaurants in the Royalty Pool were $176,364,000 for the quarter, an increase of $117,066,000...

Continue reading

Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic

Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic

INSIDE INFORMATION The acquisition will result in the business combination of Bone Therapeutics and Medsenic to create BioSenic, a speciality biopharma company 51% of Medsenic shares (valued at ca EUR 40 million) to be contributed at a subscription price per share of EUR 0.45 Each existing share to be entitled to subscribe to one additional share at EUR 0.45 in case of successful ALLOB interim results Bone Therapeutics to acquire the remaining outstanding capital of Medsenic within 36 months Mont-Saint-Guibert, Belgium, August 10, 2022, 12:00 AM CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and Medsenic, a privately held, clinical stage biopharmaceutical company incorporated in France and specialized in the development of optimized formulations of...

Continue reading

PHX Energy Announces Further Increase to its Quarterly Dividend and Strong Second Quarter Results

PHX Energy Announces Further Increase to its Quarterly Dividend and Strong Second Quarter Results

CALGARY, Alberta, Aug. 09, 2022 (GLOBE NEWSWIRE) — Second Quarter Highlights The Corporation’s adjusted EBITDA(1) from continuing operations increased to $25.1 million, 20 percent of consolidated revenue(1). This is the highest second quarter adjusted EBITDA in the Corporation’s history. Earnings from continuing operations of $12.8 million is also the best second quarter result in the Corporation’s history. Consolidated revenue of $126.2 million is the highest second quarter revenue on record, an increase of 67 percent over the comparative 2021-quarter. For the second consecutive quarter, PHX Energy’s US division generated its highest quarterly revenue in the Corporation’s history. US revenue was $105.4 million in the second quarter of 2022, representing 83 percent of consolidated revenue. The Corporation divested its Russian...

Continue reading

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results

SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today reported financial results for the second quarter ended June 30, 2022 and provided an update on its corporate activities and product pipeline. “We achieved a significant milestone in Cidara’s corporate evolution with the submission of an NDA for rezafungin for the treatment of candidemia and invasive candidiasis,” said Jeffrey Stein, Ph.D., President and Chief Executive Officer of Cidara. “We were also pleased to announce a license agreement with Melinta Therapeutics for the U.S. commercialization of rezafungin for up to $460 million. We expect a PDUFA target action date in the first quarter of 2023.” Dr....

Continue reading

Logan Ridge Finance Corporation Reports Second Quarter 2022 Financial Results

Logan Ridge Finance Corporation Reports Second Quarter 2022 Financial Results

Continued to execute on its strategic initiatives by significantly lowering cost of capital and reducing non-interest earning equity exposure Expects to see the full benefits of these initiatives in the second half of 2022 with improved financial and operational performance NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) — Logan Ridge Finance Corporation (“LRFC”, “Logan Ridge” or the “Company”) (Nasdaq: LRFC) today announced its financial results for the second quarter ended June 30, 2022. Management CommentaryTed Goldthorpe, Chief Executive Officer and President of LRFC, said, “The second quarter of 2022 was transformational for Logan Ridge and marks the first-year anniversary of our stewardship. Although we continue to operate in an uncertain economic environment affected by high inflation and rising interest rates, our portfolio is...

Continue reading

Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2022. The Company also announced a quarterly dividend of $0.07 per share payable to the shareholders of record as of August 24, 2022, to be paid on September 9, 2022. The Company’s revenue for the quarter ended June 30, 2022, was $6.5 million versus $6.1 million for the quarter ended June 30, 2021, an increase of 7%. Net loss for the quarter ended June 30, 2022, was $0.3 million or ($0.06) per diluted share, versus net income of $0.1 million or $0.02 per diluted share, for the comparable period last year, a decrease of $0.08 per diluted share. The Company’s revenue for the six months ended June 30, 2022, was...

Continue reading

Osisko Declares Third Quarter 2022 Dividend

Osisko Declares Third Quarter 2022 Dividend

MONTREAL, Aug. 09, 2022 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (OR: TSX & NYSE) is pleased to announce a third quarter 2022 dividend of C$0.055 per common share. The dividend will be paid on October 14, 2022 to shareholders of record as of the close of business on September 30, 2022. This dividend is an “eligible dividend” as defined in the Income Tax Act (Canada). For shareholders residing in the United States, the U.S. dollar equivalent will be determined based on the daily rate published by the Bank of Canada on September 30, 2022. The Company also wishes to remind its shareholders that it has implemented a dividend reinvestment plan (the “Plan”). Shareholders who are residents of Canada and the United States may elect to participate in the Plan in connection with the dividend...

Continue reading

Shift and CarLotz Agree To Merge, Creating a Differentiated Used Auto Ecommerce Retailer

Shift and CarLotz Agree To Merge, Creating a Differentiated Used Auto Ecommerce Retailer

Merger will create a leading omnichannel auto retailer Combination of complementary geographic footprints, with Shift’s strong presence on the West Coast and CarLotz’s retail stores in the mid-Atlantic region Upon close, combined company anticipated to have a cash position of approximately $125 million SAN FRANCISCO and RICHMOND, Va., Aug. 09, 2022 (GLOBE NEWSWIRE) — Shift Technologies, Inc. (Nasdaq: SFT), a leading end-to-end ecommerce platform for buying and selling used cars, and CarLotz, Inc. (Nasdaq: LOTZ), a leading consignment-to-retail used vehicle marketplace, announced today that they have entered into a definitive agreement to combine in a stock-for-stock merger. The combined company will continue to trade on Nasdaq under the ticker SFT. The combination will create the destination for the best online and in-person...

Continue reading

Shift and CarLotz Agree To Merge, Creating a Differentiated Used-Auto Ecommerce Retailer

Shift and CarLotz Agree To Merge, Creating a Differentiated Used-Auto Ecommerce Retailer

Merger will create a leading omnichannel auto retailer Combination of complementary geographic footprints, with Shift’s strong presence on the West Coast and CarLotz’s retail stores in the mid-Atlantic region Upon close, combined company anticipated to have a cash position of approximately $125 million SAN FRANCISCO and RICHMOND, Va., Aug. 09, 2022 (GLOBE NEWSWIRE) — Shift Technologies, Inc. (Nasdaq: SFT), a leading end-to-end ecommerce platform for buying and selling used cars, and CarLotz, Inc. (Nasdaq: LOTZ), a leading consignment-to-retail used vehicle marketplace, announced today that they have entered into a definitive agreement to combine in a stock-for-stock merger. The combined company will continue to trade on Nasdaq under the ticker SFT. The combination will create the destination for the best online and in-person...

Continue reading

Porch Group Reports Second Quarter 2022 Results

Porch Group Reports Second Quarter 2022 Results

– Reports $70.8 Million of Revenue, up 38% Year-Over-Year – Executes Mutual Termination of CSE Insurance Acquisition, Increasing Expected End-of-Year Unrestricted Cash Position by Approximately $50 Million – Provides Updated 2022 Guidance SEATTLE, Aug. 09, 2022 (GLOBE NEWSWIRE) — Porch Group, Inc. (“Porch Group” or “the Company”) (NASDAQ: PRCH), a leading vertical software company reinventing the home services and insurance industries, today reported second-quarter results for the Company as of June 30, 2022, with revenues of $70.8 million, compared to second-quarter 2021 revenues of $51.3 million, highlighting both organic growth and the strength of businesses acquired in the prior twelve month period. For the six months ended June 30, 2022, Porch Group reported revenues of $133.3 million, compared to $78.1...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.